| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of GM2A mRNA | CTD | PMID:14664709 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GM2A mRNA | CTD | PMID:19770486 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:628651 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GM2A mRNA | CTD | PMID:20959002 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:628651 | 6480464 | 2,4-dinitrotoluene affects the expression of GM2A mRNA | CTD | PMID:21346803 |
| 3,4-methylenedioxymethamphetamine | increases expression | EXP | | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of GM2A mRNA | CTD | PMID:20188158 |
| 4,4'-diaminodiphenylmethane | increases expression | EXP | | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of GM2A mRNA | CTD | PMID:18648102 |
| aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of GM2A mRNA | CTD | PMID:19770486 |
| aflatoxin B1 | increases expression | ISO | RGD:1353976 | 6480464 | Aflatoxin B1 results in increased expression of GM2A mRNA | CTD | PMID:21641981 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1353976 | 6480464 | Tretinoin results in increased expression of GM2A mRNA | CTD | PMID:15894607 |
| ammonium chloride | affects expression | ISO | RGD:628651 | 6480464 | Ammonium Chloride affects the expression of GM2A mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of GM2A mRNA | CTD | PMID:21715664 |
| biochanin A | decreases expression | ISO | RGD:1353976 | 6480464 | biochanin A results in decreased expression of GM2A mRNA | CTD | PMID:12111696 |
| cadmium sulfate | multiple interactions | ISO | RGD:1353976 | 6480464 | [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of GM2A mRNA | CTD | PMID:18654764 |
| choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of GM2A gene | CTD | PMID:20938992 |
| cisplatin | multiple interactions | ISO | RGD:1353976 | 6480464 | [Piroxicam co-treated with Cisplatin] results in increased expression of GM2A mRNA | CTD | PMID:21858171 |
| clofibrate | multiple interactions | EXP | | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of GM2A mRNA; more ... | CTD | PMID:17585979 |
| cobalt dichloride | multiple interactions | ISO | RGD:1353976 | 6480464 | [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of GM2A mRNA | CTD | PMID:18654764 |
| copper(2+) sulfate | decreases expression | ISO | RGD:1353976 | 6480464 | Copper Sulfate results in decreased expression of GM2A mRNA | CTD | PMID:19549813 |
| cyclosporin A | decreases expression | ISO | RGD:1353976 | 6480464 | Cyclosporine results in decreased expression of GM2A mRNA | CTD | PMID:20106945 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of GM2A mRNA | CTD | PMID:15513904 |
| folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of GM2A gene | CTD | PMID:20938992 |
| L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of GM2A gene | CTD | PMID:20938992 |
| maneb | multiple interactions | EXP | | 6480464 | [Paraquat co-treated with Maneb] results in decreased expression of GM2A mRNA | CTD | PMID:18386188 |
| mono(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of GM2A mRNA | CTD | PMID:22401849 |
| nickel sulfate | decreases expression | ISO | RGD:1353976 | 6480464 | nickel sulfate results in decreased expression of GM2A mRNA | CTD | PMID:16780908 |
| nickel sulfate | increases expression | ISO | RGD:1353976 | 6480464 | nickel sulfate results in increased expression of GM2A mRNA | CTD | PMID:16780908 |
| paracetamol | multiple interactions | EXP | | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of GM2A mRNA; more ... | CTD | PMID:17585979 |
| paracetamol | increases expression | ISO | RGD:1353976 | 6480464 | Acetaminophen results in increased expression of GM2A mRNA | CTD | PMID:22230336 |
| paraquat | multiple interactions | EXP | | 6480464 | [Paraquat co-treated with Maneb] results in decreased expression of GM2A mRNA | CTD | PMID:18386188 |
| perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of GM2A mRNA | CTD | PMID:17681415 |
| phenobarbital | decreases expression | ISO | RGD:628651 | 6480464 | Phenobarbital results in decreased expression of GM2A mRNA | CTD | PMID:19162173 |
| phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of GM2A mRNA | CTD | PMID:23091169 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GM2A mRNA | CTD | PMID:19710929 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of GM2A mRNA | CTD | PMID:17426115 more ... |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of GM2A mRNA | CTD | PMID:17426115 more ... |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of GM2A mRNA | CTD | PMID:20059764 more ... |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of GM2A mRNA | CTD | PMID:20059764 more ... |
| pirinixic acid | multiple interactions | EXP | | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in decreased expression of GM2A mRNA] | CTD | PMID:20059764 PMID:17950772 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of GM2A mRNA | CTD | PMID:20813756 more ... |
| pirinixic acid | multiple interactions | EXP | | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in decreased expression of GM2A mRNA] | CTD | PMID:17950772 PMID:20059764 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid co-treated with PPARA] results in decreased expression of GM2A mRNA | CTD | PMID:20813756 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of GM2A mRNA | CTD | PMID:17426115 more ... |
| piroxicam | multiple interactions | ISO | RGD:1353976 | 6480464 | [Piroxicam co-treated with Cisplatin] results in increased expression of GM2A mRNA | CTD | PMID:21858171 |
| tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of GM2A mRNA | CTD | PMID:17484886 |
| trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of GM2A mRNA | CTD | PMID:19448997 |
| valproic acid | increases expression | ISO | RGD:1353976 | 6480464 | Valproic Acid results in increased expression of GM2A mRNA | CTD | PMID:19101580 |
| vancomycin | increases expression | EXP | | 6480464 | Vancomycin results in increased expression of GM2A mRNA | CTD | PMID:18930951 |
| zinc atom | increases expression | ISO | RGD:1353976 | 6480464 | Zinc deficiency results in increased expression of GM2A mRNA | CTD | PMID:18356318 |
| zinc(0) | increases expression | ISO | RGD:1353976 | 6480464 | Zinc deficiency results in increased expression of GM2A mRNA | CTD | PMID:18356318 |